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Background: Post-stroke hyperglycemia appears to be associated with poor outcome from stroke, greater
mortality, and reduced functional recovery. Focal cerebral ischemia data support that neural stem cells (NSCs) play
an important role in post-ischemic repair. Here we sought to evaluate the negative effects of hyperglycemia on the
cellular biology of NSCs following anoxia, and to test whether high glucose affects NSC recovery from ischemic
injury.
Results: In this study, we used immortalized adult neural stem cells lines and we induced in vitro ischemia by 6 h
oxygen and glucose deprivation (OGD) in an anaerobic incubator. Reperfusion was performed by returning cells to
normoxic conditions and the cells were then incubated in experimental medium with various concentrations of
glucose (17.5, 27.75, 41.75, and 83.75 mM) for 24 h. We found that high glucose (≥27.75 mM) exposure induced
apoptosis of NSCs in a dose-dependent manner after exposure to OGD, using an Annexin V/PI apoptosis detection
kit. The cell viability and proliferative activity of NSCs following OGD in vitro, evaluated with both a Cell Counting
kit-8 (CCK-8) assay and a 5-ethynyl-2’-deoxyuridine (EdU) incorporation assay, were inhibited by high glucose
exposure. Cell cycle analysis showed that high glucose exposure increased the percentage of cells in G0/G1-phase,
and reduced the percentage of cells in S-phase. Furthermore, high glucose exposure was found to significantly
induce the activation of c-Jun N-terminal protein kinase (JNK) and p38 mitogen-activated protein kinase (MAPK)
and suppress extracellular signal-regulated kinase 1/2 (ERK1/2) activity.
Conclusions: Our results demonstrate that high glucose induces apoptosis and inhibits proliferation of NSCs
following OGD in vitro, which may be associated with the activation of JNK/p38 MAPK pathways and the delay of
G1-S transition in the cells.
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Stroke has become the leading cause of morbidity and
mortality in China, amounting to 1.65 million deaths
and 2 million new onsets every year, rising on average by
8.4% each year [1]. Despite intensive investigations into
the mechanism and treatment of stroke, very limited
effective therapies are available for stroke patients.
Compared with the very limited traditional therapies, such* Correspondence: tansheng18@126.com
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reproduction in any medium, provided the oras neuroprotective strategies, some new neuroregenerative
therapies involving endogenous or exogenous approaches
are promising. Recent reports have shown that endogen-
ous and transplanted neural stem cells (NSCs) can be
activated by cerebral ischemia and take part in the regen-
eration of neural function [2,3]. However, some basic
questions concerning the fate of NSCs after an ischemic
or hypoxic insult remain to be answered. Low survival and
insufficient neuronal differentiation of endogenous or
engrafted NSCs within the ischemic core and peri-infarct
regions hamper the efficacy of NSC therapy and limit its
clinical applications [4]. Therefore, understanding the
cellular biology of NSCs within an ischemic or hypoxic
environment could give rise to new possibilities fortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of novel cell replacement therapies after ischemic stroke.
NSCs within the adult brain germinal centers reside in
a specialized micro-environmental niche that regulates
cell migration, adhesion, proliferation and differentiation
under both physiological and pathological conditions
[5-7]. Among various incidents during cerebral ischemia,
the reduction in the supply of oxygen (hypoxia) and
glucose (hypoglycemia) in the brain is a major factor me-
diating neural damage [8]. It has recently been reported
that the proliferation of cultured NSCs is promoted by
hypoxia, and NSCs are resistant to ischemia-induced
apoptosis [9,10]. However, there are a low number of
NSCs that can survive for a long time and contribute to
the reconstruction of neural circuitry [4]. It is believed
that the glucose level is a crucial factor for the self-
renewal and multipoietic activities of NSCs following
cerebral ischemia. There are reports showing that low
glucose suppresses the proliferation and increases the
differentiation of cultured NSCs in vitro [8], and that
post-stroke hyperglycemia is seen in up to 50% of patients
who have an initial blood glucose above 6.0–7.0 mM
[11,12]. Hyperglycemia appears to be associated with
more severe stroke, assessed either with a clinical stroke
scale [13] or by lesion volume. Plasma glucose is an
important determinant of brain injury in experimental
models of focal cerebral ischemia/reperfusion [14], but
few studies have explored the effect of high glucose on
NSCs or progenitor cells following oxygen and glucose
deprivation/reperfusion (OGD/R) insult.
In this study, we first assessed the effects of high
glucose on the proliferation and apoptosis of NSCs using
an in vitro ischemic model. We further examined
whether the activation of mitogen-activated protein
kinase (MAPK) signaling molecules is involved in the
proliferation and apoptosis of NSCs, as MAPK signaling
plays an important role in central nervous system (CNS)
development and differentiation [15]. We found that
mild elevated glucose facilitated the survival of NSCs
after hypoxia, whereas higher glucose exacerbated the
hypoxia-mediated injury, with a G1/S transition delay
and the activation of c-Jun N-terminal kinase (JNK) and
p38 MAPK signaling molecules. These findings may
have important implications for glycemic control in
stroke patients, and provide a further understanding of
the fate of NSCs following cerebral ischemia.
Methods
Cell culture
Adult rat neural stem cells (NSCs) were purchased from
Chemicon, Inc.(Billerica, MA, USA), and maintained by
an adherent monoculture method developed by Palmer
et al. [16]. It is recommended to grow the cells in the
routine commercial Neural Stem Cell Basal Media(Cat. No. SCM009, Millipore, Billerica, MA, USA)
containing 17.5 mM glucose (used as the control level
in this study), which has been optimized for the growth
and in vitro differentiation of NSCs derived from
rodents. To estimate the effects of high glucose on the
survival and proliferation of NSCs following in vitro
ischemia, we used in vitro concentrations of 27.75,
41.75, and 83.75 mM glucose, which are similar to
in vivo levels of glucose under "diabetes mellitus",
"diabetic ketoacidosis", and "hyperglycemia hyperosmolar
status" conditions, respectively. High glucose conditions
(27.75, 41.75, and 83.75 mM) were established by addition
of D-glucose to Neural Stem Cell Basal Media. Briefly, the
cells were plated onto poly-L-ornithine- and laminin-
(Cat. No. P3655, L2020, Sigma-Aldrich, Inc., St. Louis,
MO, USA) coated 60 mm culture dishes or 96-well plates.
After reaching 50% confluence, the cells were left in
anoxic conditions for an appropriate duration to induce an
OGD/R insult. The cells were then exposed to the experi-
mental media with various concentrations of D-glucose for
24 h. Mannitol was used as a control to exclude a possible
effect of osmolality on cell viability. We changed the
mannose concentrations to keep the osmotic pressure of
the culture medium at various glucose concentrations.
Thereafter, cells were harvested for analysis.
Oxygen glucose deprivation/reperfusion procedure
To induce OGD, NSCs were grown in 60 mm culture
dishes or 96-well plates for 24 h. Then they were washed
twice with Earle’s balanced salt solution (EBSS) (g/L:
NaCl 6.80, KCl 0.4, CaCl2 0.2, MgSO4 0.2, NaH2PO4
1.14, NaHCO3 2.2, phenol red 0.02). The cells were then
immersed in 5 mL (for 60 mm petri dishes) or 100 μL
(for 96-well plates) of glucose-free NBM-B27 media
(Neurobasal glucose-free, Invitrogen, Carlsbad, CA, USA)
with 25 mM L-glutamate (Sigma–Aldrich) before the
plates were transferred into a CO2/O2 tri-gas incubator
(Forma 3131, Thermo Fisher Scientific Inc., Asheville, NC,
USA) with an atmosphere of 1% O2, 5% CO2 and 94% N2,
98% humidity at 37°C. The incubator was flooded with
pre-warmed and humidified gas consisting of 5% (v/v)
CO2 in 95% N2. Oxygen and CO2 content in the wells
were continuously maintained at a constant level by the
tri-gas incubator with a precise gas sensor. The cells were
left in the incubator for different durations (2, 4, 6, 8 and
10 h). Reperfusion was performed by removing the plates
from the incubator, immediately washing twice with EBSS
and adding an equal volume of neural stem cell basal
medium supplemented with 20 ng/mL basic fibroblast
growth factor (b-FGF) (Millipore, Cat. No. GF003). The
cells were then returned to a CO2 incubator (Forma 3110,
Thermo Fisher Scientific Inc.) with an atmosphere of 5%
CO2, 95% air, and 98% humidity at 37°C for 24 h. To
induce OGD/R of NSCs in vitro, the induction of 50%
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examined by light microscopy (IX700, Olympus, Tokyo,
Japan) for qualitative assessment of NSC damage. For
quantitative measurements of cell viability, we used a
WST-8 assay (Dojindo Laboratories, Kumamoto, Japan).
Cell viability tests
To estimate the number of viable cells, approximately
50,000 cells were grown in each well of poly-L-lysine-
coated 96-well plates with 100 μL medium. We performed
a WST-8 assay with the Cell Counting Kit-SF (Dojindo
Laboratories, Kumamoto, Japan) using the methods
described by Horie et al [8]. Cell Counting Kit-8 solution
was added to the cell culture medium to a final concentra-
tion of 5 μL/100 μL, and incubated for an additional 4 h at
37°C. We measured the absorbance at 450 nm with a
reference wavelength of 630 nm with a microplate reader
(ELx800, BioTek instruments, Inc., Winooski, VT, USA). In
each experiment, at least three parallel wells were set up.
Using these experimental procedures, we obtained a good
linear relationship between the net absorbance and the
viable cell density.
EdU incorporation assay
We assessed proliferation of the cells using the 5-ethynyl-
2’-deoxyuridine (EdU) incorporation assay. NSCs were
incubated with EdU to see which fraction of cells showed
proliferative activity. The EdU incorporation assay was
performed with a Cell-Light EdU kit (Ribobio Co., Ltd.,
Guangzhou, China) according to the manufacturer’s
instructions. Briefly, NSCs were cultured in a well of a
96-well plate coated with poly-D-lysine at a cell density of
5000 cells per well, and the cells were then labeled with
50 μM EdU (1:1000) and incubated for an additional 2 h
before the cells were fixed with 4% formaldehyde for
15 min at room temperature and treated with 0.5%
Triton X-100 for 20 min at room temperature for
permeabilization. After washing with PBS three times, each
well of cells was reacted with 100 μL of 1× ApolloW
reaction cocktail for 30 min. Subsequently, the DNA
content of each well of cells was stained with 50 μL
DAPI (Vector Laboratories, Inc., Burlingame, CA, USA)
for 30 min and mounted. EdU-labeled cells were
counted using fluorescence microscopy (CKX41-F32FL,
Olympus). and normalized to the total number of DAPI-
stained cells.
Cell cycle analysis
The effect of different concentrations of glucose on the
cell cycle was measured by flow cytometry, as described
by Chen et al. [17]. Briefly, NSCs at 1 × 106 cells per plate
were cultured in 60 mm plates coated with poly-D-lysine.
At the end of the experiments, cells were dissociated using
Accutase™ (Cat. No. SCR005, Millipore) and harvested,followed by 75% ice cold ethanol fixation overnight at -20°C.
Fixed cells were stained with propidium iodide (BD
Biosciences, San Jose, CA, USA) (50 μg/mL) containing
50 μg/mL RNase A (BD Biosciences) for 30 min at 37°C
in the dark, and subsequently analyzed by fluorescence-
activated sorting (FACSCalibur, BD Biosciences). We
evaluated the changes in cell cycle distribution and
calculated the proliferation index (PI) and S-phase
cell fraction (SPF). The following formula was used:
PI = (S + G2/M)/(G0/G1 + S + G2/M), SPF = S/(G0/G1 +
S + G2/M).
Assessment of necrosis and apoptosis of NSCs
The quantitative assessment of NSC necrosis and apoptosis
was performed by flow cytometry. Briefly, NSCs were
cultured in 60 mm plates coated with poly-D-lysine at a
density of 1 × 106 cells per plate. At the end of the ex-
periments, cells were dissociated using Accutase™ and
harvested, then stained with Annexin V and PI for 15 min
at 37°C in the dark using the Annexin V-FITC apoptosis
detection kit (BD Biosciences). Subsequently, the labeled
cells were assessed by a FACSCalibur instrument.
Immunostaining
To confirm neural stem and/or progenitor status of the
starting cell population, immunostaining was performed
using the protocol below. NSCs seeded in a 96-well plate
were fixed in PBS containing 4% paraformaldehyde for
30 min at room temperature and permeabilized by
incubation with 0.3% Triton X-100 for 20 min. After
three washes with PBS, the cells were blocked with 10%
normal goat serum (Invitrogen) for 30 min. The cells
were then incubated overnight with anti-nestin antibody
(Cat. No. sc-58813, 1:800, mouse monoclonal antibody,
Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).
After removal of the primary antibody solution, the cells
were washed with PBS three times and incubated with
secondary antibody (Alexa FluorW 594 goat anti-mouse
IgG, Cat. No. 115-585-003, The Jackson Laboratory,
Sacramento, CA, USA) and 5 μg/mL of DAPI for nuclear
staining for 4 h at 37°C under light-shading conditions.
After three washes, the cells were mounted with
Perma-Fluor Aqueous Mounting Medium (Thermo
Fisher Scientific Inc.) and the fluorescent images were
viewed and captured under a fluorescence microscope
(Olympus). For estimation of the homogeneity of
NSCs, we counted the numbers of nestin-positive cells
(positive NSCs) during different passages.
Western blot analysis
To determine the amounts of phosphorylated ERK, JNK
and p38, cells were washed with PBS and harvested with
RIPA lysis buffer (20 mM Tris-HCl, pH 7.6, 150 mM
NaCl, 1% Triton X-100, 2 mM PMSF, KeyGen Biotech,
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inhibitor cocktail (KeyGen Biotech), and incubated on
ice for 30 min. All cell lysates were cleared by centrifuga-
tion (14,000 × g for 20 min at 4°C). Protein concentrations
were quantified by BCA assay (KeyGen Biotech), and
equal amounts of protein from each sample were boiled
for 5 min in sample buffer containing 62.5 mM Tris-HCl,
pH 6.8, 2% SDS, 5% glycerol, 2.5% β-mercaptoethanol,
and 0.1% bromophenol blue (KeyGen Biotech). Protein
samples were fractionated by 10% SDS-polyacrylamide gel
electrophoresis in electrophoresis buffer containing
25 mM Tris-HCl, 192 mM glycine, and 0.1% SDS for
30 min at 80 V and 90 min at 120 V, and transferred onto
a polyvinylidene difluoride membrane (EMD Millipore,
Darmstadt, Germany) for 1 h at 80 V. The membranes
were blocked with a blocking buffer containing 20 mM
Tris-HCl, pH 7.6, 137 mM NaCl, and 0.1% Tween 20
(TBST) supplemented with 5% non-fat milk overnight at
4°C. The following primary antibodies were used and
incubated for 4 h at 4°C: rabbit monoclonal anti-p-ERK 1/
2 (Cat. No. 3179S, 1:500, Cell Signaling Technology, Inc.,
Danvers, MA, USA), mouse polyclonal anti-ERK1/2
(Cat. No. sc-135900, 1:150, Santa Cruz Biotechnology, Inc.),
mouse monoclonal anti-p-JNK (Cat. No. 9255S, 1:500, Cell
Signaling Technology, Inc.), rabbit polyclonal anti-JNK2
(Cat. No. sc-827, 1:150, Santa Cruz Biotechnology, Inc.),
rabbit polyclonal anti-p-p38 (Cat. No. 9216, 1:500, Cell
Signaling Technology, Inc.), rabbit polyclonal anti-p38
(Cat. No. sc-7149, 1:150, Santa Cruz Biotechnology, Inc.).
Subsequently, the membrane was incubated with a
secondary antibody conjugated with IRDyeW infrared dyes
(LI-COR Biosciences, Lincoln, NE, USA).at a 1:15,000
dilution in TBST for 1 h. Signals were detected by
an OdysseyW CLx Infrared Imaging System (LI-COR
Biosciences). The housekeeping protein β-actin was
used as a control and tested simultaneously with a
mouse monoclonal antibody (Cat. No. sc-47778, 1:500,
Santa Cruz Biotechnology, Inc.). Western blotting data
were analyzed with Gel-Pro analyzer software 4.0
(Media Cybernetics, Rockville, MD, USA), and the ratios
of phosphorylated ERK2/total ERK2, phosphorylated
JNK/total JNK and phosphorylated p38/total p38 pixels
were calculated.
Statistics
All results were collected as the average of at least
six independent experiments. Data are presented as
the mean ± standard deviation (SD). SPSS version
13.0 (SPSS, Chicago, IL, USA) was used for statistical
analysis. Statistical analysis of the data for multiple
comparisons was performed by one-way analysis of
variance, and the Bonferroni test was used for post
hoc comparison to controls. A value of P < 0.05 was
considered statistically significant.Results
A simple, stable and reliable model of NSC OGD/R was
successfully established in vitro
To confirm the neural stem and/or progenitor status of
the starting cell population, NSCs were subjected to
immunocytochemistry before the anaerobic incubation.
We found that the great majority (94.6%) of cells expressed
nestin, a neural progenitor marker (Figure 1a), which
indicates that most of the cells had stem and/or progenitor
status. OGD/R was induced by a wash in glucose-free
EBSS prior to a 2–10 h anaerobic incubation followed by a
24 h post-incubation period. In this model (Figure 1b),
in vitro ischemia ≤ 2 h resulted in little or no injury of
NSCs, while ischemia between 4–6 h produced mild to
moderate injury, characterized by cell shrinkage with few
or no cells swelling. Ischemia > 6 h caused progressive
NSC apoptosis and the percentage of apoptotic cells
increased to 50–90%. The results of the Cell Counting kit
(CCK)-8 assay for viability reflected the light-microscopic
observations of cell death. Ischemic incubation > 6 h
decreased the cell survival rates to 50% (Figure 1c). We
found that 6 h of ischemic incubation was a threshold,
as cell survival rates decreased dramatically in response to
in vitro ischemia after this time point. Thus, an in vitro
ischemia incubation time > 6 h is necessary to induce
significant cell injury.
High glucose diminished the proliferation of NSCs
following in vitro ischemia
We evaluated the proliferative activity of NSCs incu-
bated in various concentrations of glucose for 24 h after
6 h ischemia. 5-ethynyl-2’-deoxyuridine (EdU) incorpor-
ation was decreased compared with 17.5 mM glucose
(control) when cell cultures were exposed to higher
glucose (Figure 2a, 2b). We found that cell viability for
all the cultures examined was over 90% at the beginning
of the experiment. As shown in Figure 2c, the viable
cells in 27.75 mM glucose medium were approximately
90.73% ± 10.63% of control, and the viable cells in the
higher glucose concentrations, 41.75 and 83.75 mM,
were reduced to 75.46% ± 8.53% and 46.92% ± 4.34% of
control, respectively, suggesting that the proliferation of
NSCs was further suppressed by higher glucose concentra-
tions. Compared with the control, there was a significant
decrease in EdU incorporation and cell viability in the
cultures exposed to 41.75 and 83.75 mM glucose (P < 0.05),
but not in the cells exposed to 27.75 mM glucose. The
influence of osmolality on cell viability was excluded in
this study (Table 1). These findings suggest that continuous
culture at a moderately high concentration of glucose
(27.75 mM) did not significantly inhibit the proliferative
activity of NSCs, but higher concentrations of glucose
(41.75 or 83.75 mM) significantly diminished the pro-
liferation potential of NSCs.
Figure 1 Establishment of an adult neural stem cell in vitro model of ischemia. (a) The identification of adult neural stem cells throughout
different passages. Immunocytochemical detection of nestin (red) was performed. The nuclei of NSCs were revealed by DAPI staining (blue). The
scale bar represents 20 μm. (b) Digital photomicrographs of NSCs exposed to different durations of in vitro ischemia. NSCs were subjected to
OGD for different periods (0–10 h), then were returned to normoxic conditions and incubated for an additional 24 h. The cells were
photographed at the end of the experimental period. All photomicrographs are from different sister cultures from the same plating. Minor
adjustments to brightness, contrast and color balance have been made to the digital images. The scale bar represents 20 μm. (c) Cell viability and
survival rate of the NSCs following in vitro ischemia. To estimate the number of viable cells, approximately 50,000 cells were grown in each well
of poly-L-lysine-coated 96-well plates with 100 μL medium and the absorbance at 490 nm was directly proportional to the number of viable
NSCs per well at each time point. Data points represent the mean ± SD of six independent experiments. *P < 0.05 versus control, analyzed by
one-way ANOVA/Bonferroni post hoc test.
Chen et al. BMC Neuroscience 2013, 14:24 Page 5 of 11
http://www.biomedcentral.com/1471-2202/14/24High glucose decreased the proliferation of NSCs
following in vitro ischemia by delaying the G1-S transition
We analyzed the cell cycle of NSCs by fluorescence-
activated cell sorting (FACS) after treatment with differ-
ent concentrations of glucose. As illustrated in Table 2,
we identified approximately 66.5% of NSCs in mitotic
phase in the total NSCs cultured in the basal culture
medium control (17.5 mM glucose) (proliferation index
(PI) = 0.665 ± 0.142). PI and S-phase cell fraction (SPF)
were significantly decreased compared with the controlin the cultures exposed to higher glucose (P < 0.01). The
percentage of cells in G0/G1-phase increased significantly,
whereas the percentage of cells in S-phase decreased
compared with the control in all the higher glucose
groups (Figure 3a).
High glucose induced apoptosis of NSCs following in vitro
ischemia
To determine the effects of various concentrations of
glucose on NSC apoptosis, we performed flow cytometry
Figure 2 The proliferation and viability of NSCs in high glucose were analyzed using the EdU incorporation assay and CCK-8
assay. (a) EdU-labeled cells appear in purple as the EdU (red) is colocalized with DAPI (blue). The scale bar represents 20 μm. (b) Note the
decreased number of EdU-positive cells in NSCs exposed to high glucose (41.75 or 83.75 mM), indicating less proliferation. However, there
was no difference in EdU incorporation between the 27.75 mM glucose treatment and control. % of EdU/DAPI means percentage of EdU-
positive cells in NSCs. *P < 0.01 versus control, analyzed by one-way ANOVA/Bonferroni post hoc test versus the normal glucose group
(17.5 mM glucose). (c) High glucose exposure caused a significant decrease in the viability of NSCs following OGD. *P < 0.01 versus control,
analyzed by one-way ANOVA/Bonferroni post hoc test.
Table 2 Effect of glucose on the cell cycle of NSCs
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OGD. After reoxygenation in 17.5, 27.75, 41.75, and
83.75 mM glucose medium for 24 h after 6 h of hypoxic/
ischemic treatment, the percentages of apoptotic NSCs
were 11.01 ± 0.61%, 38.86 ± 4.94%, 61.81 ± 3.53%, andTable 1 The effect of osmolality on the viability of adult
NSCs (n = 6, mean ± SD)
Group D-glucose D-glucose + D-Mannitol P
Control 2.346 ± 0.033 — —
27.75 mM 2.283 ± 0.044* 2.257 ± 0.044 0.324
41.75 mM 2.165 ± 0.041* 2.201 ± 0.068 0.293
83.75 mM 1.330 ± 0.029* 1.319 ± 0.574 0.679
F 955.900 502.976
P 0.000 0.000
*P < 0.05 vs. control.
following in vitro ischemia (n = 6, mean ± SD)
Glucose (mM) PI P SPF P
17.5 0.665 ± 0.142 - 0.515 ± 0.014 -
27.75 0.595 ± 0.026 0.002 0.465 ± 0.042 0.016
41.75 0.382 ± 0.019 0.000 0.273 ± 0.024 0.000
83.75 0.217 ± 0.042 0.000 0.176 ± 0.008 0.000
F 333.252 239.024
P 0.000 0.000
Proliferation Index (PI) = (S + G2/M)/(G0/G1+ S + G2/M), S-phase cell Fraction
(SPF) = S/(G0/G1 + S + G2/M). The data are expressed as the mean ± SD of six
independent experiments, and analyzed by one-way ANOVA followed by
Bonferroni test versus the normal glucose group (17.5 mM glucose).
Figure 3 The effect of various concentrations of glucose on the cell cycle and apoptosis of NSCs following in vitro ischemia. (a) The cell
cycle distribution of NSCs was analyzed by flow cytometry. The percentage of NSCs in G0/G1-phase was significantly increased, whereas the
percentage of NSCs in S-phase was markedly decreased, compared with the control in all there higher glucose groups. (b) The apoptosis of NSCs
was quantified by flow cytometry. Relative fluorescence in NSC populations was double-stained with Annexin V (AV)-FITC and propidium iodide
(PI). In each panel, AV-/PI- cells are viable NSCs, shown in the lower-left quadrant. The AV+/PI + cells represent late apoptotic NSCs, shown in the
upper-right quadrant, and the AV+/PI- cells represent early apoptotic NSCs, shown in the lower-right quadrant. AV-/PI + cells, representing
necrotic NSCs, are shown in the upper-left quadrant. The proportion of apoptotic cells (both in early and late phase apoptosis) is higher in all the
other three glucose groups compared with the control.
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cells was significantly increased in the three higher glucose
groups (27.75, 41.75, and 83.75 mM glucose) compared
with the control group (17.5 mM glucose) (P < 0.01)
(Figure 3b).High glucose activated JNK and p38 MAPKs in NSCs
following in vitro ischemia
To further understand the mechanism by which high
glucose suppressed the proliferation of NSCs, we investi-
gated the phosphorylation of ERK, JNK and p38 MAPK
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glucose. As shown in Figure 4, total ERK2, total JNK2 and
total p38 were consistently expressed and no significant
changes were found between the control group and the
higher glucose groups. For the phosphorylated proteins,
we found that the level of p-ERK significantly decreased in
the NSCs treated with 41.75 and 83.75 mM glucose after
6 h of ischemia, but there were no significant changes in
the cells treated with 27.75 mM glucose compared with
the control (Figure 4a). The levels of p-p38 and p-JNK2
significantly increased in the three higher glucose groups
(27.75, 41.75, and 83.75 mM glucose) compared with the
control (Figure 4b, 4c).
Discussion
Recent studies have demonstrated the potential for
endogenous and transplanted neural stem/progenitor
cells (NSPCs) to ameliorate the structural and behavioral
deficits associated with cerebral ischemia in animal
models [2], providing a potential therapy for ischemicFigure 4 The effect of various concentrations of glucose on the activa
ischemia. Significant changes in the levels of phosphorylated ERK, JNK and
glucose following in vitro ischemia. (a) The p-ERK2 level was decreased in N
exposure, but no significant change in the p-ERK2 level was observed betw
group. (b-c) Both p-p38 and p-JNK significantly increased in NSCs of the th
with the normal glucose group cells. *P < 0.05 versus control, analyzed by ostroke. However, poor NSPC survival within the ische-
mic core and peri-infarct regions following stroke has
hampered the benefits and applications of cell-based
therapies [18,19]. Many factors are involved in the
regulation of the biological behaviors of NSCs, including
genetics, growth factors, neurotransmitters, stress, hor-
mones, and environmental factors like hypoxia. Recent
studies have shown that the availability of glucose, but
not of oxygen, is a restricting factor for NSC survival
and proliferation following hypoxic/ischemic damage [9].
Furthermore, the proliferation of certain developmental
stage-specific cells, such as embryonic and postnatal
NSCs, has been proven to be dependent on the glucose
concentration under physiological and pathological con-
ditions such as diabetes [20-22]. It is increasingly evident
that post-stroke hyperglycemia is associated with poor
outcome, and seems to particularly affect outcome in
patients without diabetes [23,24]. With regard to cere-
bral ischemia/reperfusion pathophysiology, it is reported
that hyperglycemia exacerbates brain injury due to poortion of ERK, JNK and p38 MAPKs in NSCs following in vitro
p38 were observed in NSCs exposed to different concentrations of
SCs treated with 41.75 and 83.75 mM glucose after 6 h ischemic
een the normal glucose group (17.5 mM) and the 27.75 mM glucose
ree glucose treatment groups (27.75, 41.75, and 83.75 mM) compared
ne-way ANOVA/Bonferroni post hoc test.
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lactate and intracellular acidosis in the ischemic brain
[25-27], and enhancement of the inflammatory response
[26]. Whether the harmful effects of hyperglycemia are
mediated by exacerbating the ischemic injury in NSCs
or NPCs is unclear. So far, little is known about the
effect of high glucose on the proliferation of adult neural
stem cells following in vitro ischemia. In this study, we
found that exposure to high glucose induced apoptosis
of NSCs in a dose-dependent manner and inhibited the
viability and proliferation of NSCs following OGD
in vitro. Furthermore, we observed prolonged activation
of JNK/p38 MAPK, suppressed ERK1/2 activity, and an
increased percentage of cells in G0/G1-phase in NSCs
treated with high glucose. In conclusion, our results
indicate that high glucose induces the apoptosis and
inhibits the proliferation of NSCs following OGD
in vitro, which may be associated with a prolonged
activation of JNK/p38 MAPK pathways and a delay of
the cell G1-S transition.
Since glucose concentrations can be controlled and
the actions of extrinsic factors can be delineated in an
in vitro culture system, we used immortalized adult
NSCs to investigate the effects of high glucose on the
proliferation of NSCs using a well-characterized in vitro
OGD model. The NSCs were isolated from the hippo-
campus of adult Fisher 344 rats, widely used for a variety
of research applications including drug development,
studies of neurotoxicity, neurogenesis, electrophysiology,
neurotransmitter and receptor functions, and CNS dis-
orders. In NSC cultures, the majority of cells kept their
neural stem and/or progenitor status during the different
passages. Most in vitro models of ischemia using neur-
onal cultures have used OGD to mimic the reduced
intracellular energy state that occurs in neuronal cells
following permanent and transient cerebral ischemia
[28-30]. These models have been used to assess whether
agents exacerbate or reduce in vitro neuronal ischemic
injury [31,32]. However, the duration of OGD that was
required to induce NSC ischemic injury was reported to
vary in different in vitro models of ischemia. Additionally,
it is common practice to culture cells in a sealed hypoxia
chamber to mimic anoxic conditions, in which the O2
level is usually approximately 0% [33], while the O2 level
observed in the anoxic environment often remains
unchanged between 0% and 1%. In our study, we used a
tri-gas incubator to adjust the O2 level in the cultures to a
constant level (1%), and determined appropriate anaerobic
incubation times by modifying and incorporating features
used in neuronal in vitro models of ischemia [34]. We
thus determined that 6 h of OGD incubation mimicked
cerebral hypoxic-ischemic injury.
In vitro systems used to study neuronal responses to
changes in ambient glucose concentrations must considerthat the glucose levels in vitro should be of practical
relevance to the brain in vivo [35,36]. The physiological or
normal blood glucose concentration in vivo can range
from 5.5–7.0 mM. Thus, 5.5 mM is usually recognized as
“englycemic” in vitro culture conditions for CNS research.
However, it is not applied to the in vitro NSC culture
media that are usually used (e.g. DMEM/F12), which
normally contain 17.5 mM glucose, a level perhaps seen in
the plasma of obese ob/ob mice. At the beginning of our
study, we were puzzled as to why the NSCs must be
grown in media with such a high glucose concentration,
rather than in media with lower glucose concentrations,
such as 7.0 mM and 5.5 mM. To address this question, we
conducted initial experiments using 7.0 mM and 5.5 mM
glucose to mimic diabetic and physiological glucose levels
in vivo, respectively. The viability of NSCs exposed to 5.5,
7.0, and 17.5 mM glucose medium for 24, 48 or 72 h was
examined by MTS assay (Figure S1, see Additional file 1,
available online). The relative increase in the number of
NSCs in each group was represented by the ratio of 72 h
viability to 24 h viability (Figure S2, see Additional file 1).
We found that the NSCs could not be grown in the
medium with 5.5 or 7.0 mM glucose, but grew well in the
medium with 17.5 mM glucose. To evaluate the effects of
high glucose on the survival and proliferation of NSCs
following in vitro ischemia, 17.5 mM glucose was chosen
as the control, and higher concentrations of glucose were
contained in the experimental medium. Thus, we used
in vitro concentrations of 27.75, 41.75, and 83.75 mM
glucose, which are similar to in vivo levels of glucose under
“diabetes mellitus”, “diabetic ketoacidosis”, and “hypergly-
cemia hyperosmolar status” conditions, respectively.
High glucose concentrations are known to have
detrimental effects on many cell types, by impairing
cellular functions and inducing cell apoptosis. High
glucose has been shown to inhibit the proliferation,
migration and in vitro angiogenic capacity of bone
marrow-derived endothelial progenitor cells [37] and to
alter the regenerative potential of mesenchymal stem
cells [38]. Furthermore, hyperglycemic conditions affect
the proliferation and apoptosis of NPCs in the develop-
ing spinal neural tube, leading to abnormal development
[39]. If elevated levels of glucose are detrimental to
neuronal survival during ischemia, does high glucose
(up to 40 mM) damage neurons and NPCs? In the present
study, exposure to high glucose (up to 41.75 mM for 24 h)
decreased viability and proliferation and increased apop-
tosis in NSCs following in vitro ischemia. Our results are
consistent with the studies reported above, but we used
different concentrations of glucose. Meanwhile, our study
also showed that high glucose treatment consistently
suppressed DNA duplication and cell division of NSCs
following in vitro ischemia by blocking the G1-S transition
of the cell cycle.
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glucose on the activation of signaling molecules from
the MAPK pathways. MAPKs include three major fam-
ilies: extracellular signal-regulated kinases 1/2 (ERK 1/2),
c-Jun N-terminal kinases (JNK), and p38 MAPKs (p38).
Upon their activation by the phosphorylation of Thr and
Tyr residues, MAPKs regulate cellular processes such as
proliferation, survival/apoptosis, differentiation, develop-
ment, adherence, motility, metabolism, and gene regulation
[40]. In the central nervous system, MAPKs are relatively
highly expressed. Previous studies suggested that the
expression or phosphorylation levels of MAPKs drastically
changed in post-ischemic brain tissues, and that the inhib-
ition of MAPK cascades could alter the outcome of ische-
mic brain injury in in vitro and in vivo experimental models
[41,42]. Therefore, we examined the phosphorylation levels
of ERK1/2, JNK and p38 in NSCs exposed to different con-
centrations of glucose after OGD. We found that the level
of p-ERK2 decreased, while the levels of p-p38 and p-JNK2
increased in the cells treated with the three higher glucose
concentrations (27.75, 41.75, and 83.75 mM glucose) com-
pared with the control. It has been reported that the role of
ERK1/2 in ischemia-mediated neuronal death is disputable
[43]. Despite the volume of evidence supporting that the
elevation of p-ERK1/2 after ischemic injury is a detrimental
effect essential for oxidative stress and inflammation-
related cell death, numerous studies have demonstrated
that ERK1/2 activation contributes to the protective effects
of many neuroprotectants. Our results showed that high
glucose decreased ERK2 phosphorylation in OGD NSCs,
resulting in less proliferation. Because JNK2 and p38 are
generally activated by the same stress signals, such as
osmotic shock and heart shock, they are referred to as
stress-activated protein kinases (SAPKs). Phosphorylation
of the p38 pathway can induce cell apoptosis and inhibition
of p38 with SB203580 can reduce cell death [44,45]. In
addition, JNK also stimulates cell apoptosis and inhibits cell
proliferation when it is activated by cell stress [46]. The
increased levels of p-JNK2/p-p38 and the decreased
level of p-ERK2 observed in our experiments may
reflect a new balance between cell growth and cell
death after cells are exposed to high glucose treatment
following in vitro ischemia.
Conclusions
Taken together, our data suggest that mild elevated
glucose after hypoxia may improve NSC recovery from
ischemic injury, while higher glucose may exacerbate the
ischemic injury through activation of JNK and p38 MAPK
signaling pathways. The actual mechanism by which high
glucose regulates ERK, JNK and p38 pathways to control
neuronal survival and death remains to be further investi-
gated. Additionally, we should emphasize that our findings
were based on in vitro studies on rat adult NSCs. Althoughthe OGD model partially mimics both ischemic and hyp-
oxic insults, in vivo investigations remain to be conducted
for a better understanding of the effect of glycemic control
on adult NSCs.
Additional file
Additional file 1: Figure S1. The viability of NSCs was examined by
MST assay after 24 h, 48 h or 72 h of growth. Neural stem cells were
exposed to 2 mM, 7 mM or 17.5 mM D-glucose. The absorbance at
490 nm is directly proportional to the number of cells in each well at
each time point. Figure S2. The relative increase in the number of neural
progenitor cells in each group is represented by the ratio of 3-day
viability to 1-day viability. The relative increase in NSCs exposed to 2 mM
and 7 mM glucose was less than that in NSCs exposed to 17.5 mM
glucose. The data are presented as the mean ± SD (n = 6) of the relative
increase in cell number. *P < 0.05; NS, not significantly different.
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